These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7339434)

  • 1. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic tolerance in man of rifampicin-isoniazid association].
    Toulet J; Plomteux G; Viteau JM; Abiven M; Bonfante N
    J Med Liban; 1971; 24(6):651-8. PubMed ID: 5146848
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
    Bobrowitz ID
    Lung; 1980; 157(3):117-25. PubMed ID: 7382540
    [No Abstract]   [Full Text] [Related]  

  • 6. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 8. Short course chemotherapy for tuberculosis: treatment of choice?
    Buechner HA
    Compr Ther; 1983 May; 9(5):59-63. PubMed ID: 6851472
    [No Abstract]   [Full Text] [Related]  

  • 9. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis.
    Kohler LJ; Gohara AF; Hamilton RW; Reeves RS
    Clin Nephrol; 1994 Oct; 42(4):263-5. PubMed ID: 7834920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service tuberculosis therapy trial.
    Israel HL
    Am Rev Respir Dis; 1974 Jul; 110(1):104. PubMed ID: 4834622
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
    Nikodemowicz E; Kamińska M; Caban M; Struzik T
    Pneumonol Pol; 1984 Oct; 52(10):503-12. PubMed ID: 6533580
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin in combination with isoniazid in the treatment childhood tuberculosis.
    Rahaju NN; Sutoto ; Rahaju N; Budiman I; Sutejo
    Paediatr Indones; 1976; 16(11-12):544-53. PubMed ID: 1088375
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse effect of etiotropic agents in patients with tuberculosis].
    Mel'nik VP
    Vrach Delo; 1991 Jun; (6):89-91. PubMed ID: 1891867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis therapy.
    Lefrock JL; Smith BR
    Am Fam Physician; 1983 Mar; 27(3):261-4. PubMed ID: 6829397
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics of tuberculosis in patients with liver cirrhosis.
    Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2007 May; 12(3):401-5. PubMed ID: 17539845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.